BDXStockBecton Dickinson & Co.
Verdicts genuinely change. Free email alert the moment BDX's does — no target price to set, unlike a price alert.
Near limit Ratio screen, 5 of 7 decided standards passing. Dow Jones Islamic, FTSE Shariah, MSCI Islamic, Usmani are within 3 points of their line. Even if they all crossed, the majority verdict would stay Not compliant. What would change it
Whether this company clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Trade plan
Posted with a stop, a target and the level that invalidates it. It resolves into the public record either way.
Why this signal?
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
Becton Dickinson & Co. (BDX) is currently considered not halal (non-compliant), per our secondary compliance provider (last assessed 2026-08-12). See the full ratio breakdown and business-activity screen below for the reasoning.
⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.
435 other Healthcare stocks pass this same screen. See compliant Healthcare stocks →
🕌 In-house Compliance Research
Computed from published company financials, balance sheet as of 2026-06-30. These ratios come from the issuer's own published statements rather than structured SEC data.
AAOIFI divides by the market cap: $50.3B as of 2026-09-06. At the 2026-11-17 close it is about $58.7B (the stored market cap moved by the share price since, not a new share count), and at that cap AAOIFI's interest-bearing debt ratio would read 28.6% (33.4% at the stored cap, against a 30% line) and interest-bearing investments ratio would read 1.5% (1.7% at the stored cap, against a 30% line). The published verdict changes only when the company is re-screened.
Business activity: cleared (no excluded categories detected)
AAOIFI Fail 2 of 3 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 33.40% | 30.00% | Fail(3.4pp over) |
| Interest-bearing investments | 1.71% | 30.00% | Pass(28.3pp buffer) |
| Non-permissible income | 0.17% | 5.00% | Pass(4.8pp buffer) |
Usmani Fail 3 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 33.13% | 33.00% | Fail(0.1pp over) |
| Interest-bearing investments | 1.70% | 33.00% | Pass(31.3pp buffer) |
| Non-liquid assets | 93.64% | at least 20.00% | Pass(73.6pp above the floor) |
| Non-permissible income | 0.17% | 5.00% | Pass(4.8pp buffer) |
MSCI Pass 4 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 33.13% | 33.33% | Pass(0.2pp buffer) |
| Cash + interest-bearing securities | 1.70% | 33.33% | Pass(31.6pp buffer) |
| Accounts receivable | 6.36% | 33.33% | Pass(27.0pp buffer) |
| Non-permissible income | 0.17% | 5.00% | Pass(4.8pp buffer) |
FTSE Pass 4 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 33.13% | 33.33% | Pass(0.2pp buffer) |
| Cash + interest-bearing securities | 1.70% | 33.33% | Pass(31.6pp buffer) |
| Accounts receivable | 6.36% | 50.00% | Pass(43.6pp buffer) |
| Non-permissible income | 0.17% | 5.00% | Pass(4.8pp buffer) |
Dow Jones Islamic Market Fail 3 of 4 ratios pass
Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 45.33% | 33.00% | Fail(12.3pp over) |
| Cash + interest-bearing securities | 2.33% | 33.00% | Pass(30.7pp buffer) |
| Accounts receivable | 6.37% | 33.00% | Pass(26.6pp buffer) |
| Non-permissible income | 0.17% | 5.00% | Pass(4.8pp buffer) |
S&P Shariah Fail 3 of 4 ratios pass
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 43.69% | 33.00% | Fail(10.7pp over) |
| Cash + interest-bearing securities | 2.24% | 49.00% | Pass(46.8pp buffer) |
| Accounts receivable | 6.15% | 49.00% | Pass(42.9pp buffer) |
| Non-permissible income | 0.17% | 5.00% | Pass(4.8pp buffer) |
MSCI M-Series Fail 3 of 4 ratios pass
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 43.69% | 33.33% | Fail(10.4pp over) |
| Cash + interest-bearing securities | 2.24% | 33.33% | Pass(31.1pp buffer) |
| Accounts receivable | 8.39% | 49.00% | Pass(40.6pp buffer) |
| Non-permissible income | 0.17% | 5.00% | Pass(4.8pp buffer) |
Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.
How close is it to flipping?
Every current reading against its own line, closest first. A verdict is only as durable as that distance.
The numbers the ratios are built from
Read from BDX's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.
| Line | Figure | As reported | Read from |
|---|---|---|---|
| RevenueTotal revenue for the period | $21.8B | 2025-09-30 | Revenues |
| Interest-bearing debtShort and long-term borrowings | $16.8B | 2026-06-30 | LongTermDebtNoncurrent, DebtCurrent |
| Cash and interest-bearing securitiesCash, equivalents and marketable securities | $863.0M | 2026-06-30 | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
| Total assetsBalance sheet total | $50.7B | 2026-06-30 | Assets |
| Market capDenominator for AAOIFI | $50.3B | live quote | price x shares |
| 36-month average market capDenominator for S&P Shariah and MSCI M-Series | $58.6B | 756 trading days | closes x shares |
| 24-month average market capDenominator for Dow Jones Islamic Market | $54.6B | 504 trading days | closes x shares |
| Non-permissible revenueInterest and excluded income | $38.0M | 2025-09-30 | InvestmentIncomeInterest |
Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.
Sources
Filing information. Balance sheet as of 2026-06-30. Income statement as of 2025-09-30. Screened 2026-09-06.
Filing links appear after the next screen: this row was screened before filing citations were recorded.
-
Total assets$50.7B
Assets· balance sheet as of 2026-06-30 -
Interest-bearing debt$16.8B
LongTermDebtNoncurrent, DebtCurrent· balance sheet as of 2026-06-30 -
Cash and interest-bearing securities$863.0M
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents· balance sheet as of 2026-06-30 -
Receivables$2.4B
AccountsReceivableNetCurrent· balance sheet as of 2026-06-30 -
Revenue$21.8B
Revenues· income statement as of 2025-09-30 -
Interest income (non-permissible)$38.0M
InvestmentIncomeInterest· income statement as of 2025-09-30 -
Market cap$50.3BMarket-data quote at screen time, 2026-09-06 · not a filing figure, so no link
What changed, and when
Verdict history for BDX. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.
- 2026-09-07 No change recorded No verdict change for BDX has been recorded since tracking began. The scan ledger records that the compliance detectors ran, not which symbols each pass covered.
Tracked since 2026-09-07.
Revenue by business segment
How BDX’s $21.8B of revenue for the fiscal year 2024-10-01 to 2025-09-30 splits across what it sells, as the company tags it in its own 10-K. The filing splits revenue by operating segment, not by product.
| Segment | Share | Revenue |
|---|---|---|
| Medical | 52.4% | $11.5B |
| Interventional | 23.9% | $5.2B |
| Life Sciences | 23.7% | $5.2B |
These are the company’s own segment names and figures. They do not say whether a line of business is permissible; our business-activity screen does.
Source: 10-K filed 2025-11-25 (accession 0000010795-25-000099), read from its XBRL on SEC EDGAR. Shares are of total revenue; subtotals and overlapping cuts the filing also tags are left out, so the lines add up to the total.
What would change the status
The headline verdict is the majority of the decided ratio standards — 5 pass and 2 fail of 7 — with a business-activity screen and any hold applied on top. Balance sheet as of 2026-06-30; market cap as stored on 2026-09-06.
Within 3 points of the line
- Usmani debt ratio: 0.1pp over
- MSCI Islamic debt ratio: 0.2pp buffer
- FTSE Shariah debt ratio: 0.2pp buffer
- Dow Jones Islamic debt ratio: 2.2pp buffer
Dow Jones Islamic, FTSE Shariah, MSCI Islamic, Usmani are within 3 points of their line. Even if they all crossed, the majority verdict would stay Not compliant.
The ratios that move with the share price
AAOIFI's debt ratio is $16.8B debt over a market cap of $50.3B (as of 2026-09-06), 33.4% against a 30% line.
At the 2026-11-17 close the market cap is about $58.7B (the stored cap moved by the share price since), so this ratio would read 28.6%; the line is -5% from there. The published status changes only when the company is re-screened.
It would pass if the market cap rose above $56.0B (+11%), about $205.69 a share against $184.74 implied by the screen's own figures.
AAOIFI would then pass; the majority verdict would stay Not compliant (6 of 7 decided standards passing), because it is held (Zoya rates it not compliant, and our screen does not overrule another screener's doubt).
At the screen's market cap, it would take $1.7B less debt to clear the line.
AAOIFI would then pass; the majority verdict would stay Not compliant (7 of 7 decided standards passing, counting every standard that divides the same figure), because it is held (Zoya rates it not compliant, and our screen does not overrule another screener's doubt).
AAOIFI's investments ratio (1.7% against a 30% line) would only fail if the market cap fell by 94%, to $2.9B. At the 2026-11-17 close it would read 1.5%.
Only AAOIFI divides by the market cap itself. The Dow Jones, S&P and MSCI M-Series standards divide by a 24- or 36-month average and the others by total assets, so a day's price move does not reach them. Figures are the screen's own; the live market cap differs from the stored one.
Shariah-compliant alternatives
Compliant companies in Medical Instruments & Supplies listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.
| Company | Market cap | Price, day |
|---|---|---|
| ISRGIntuitive Surgical Inc | $132.3B | — |
| ALCAlcon Inc. - Registered Shares | $34.7B | — |
| RMDResmed Inc. | $33.5B | — |
| WSTWest Pharmaceutical Services, Inc. | $23.9B | — |
| COOCooper Companies, Inc. | $14.8B | — |
A dash means no fresh quote is cached for that symbol; this list does not fetch one.
Funds that hold BDX
28 of the 235 funds whose filed holdings we currently hold own BDX shares. That set is a fixed list of widely held index funds and Shariah funds, plus the funds our look-through has read most recently. It is not every fund that owns BDX.
Shariah fundsBDX fails our screen. These funds follow their own Shariah screens, which can reach a different answer from ours on the same company.
| Fund | BDX in fund | Fund compliant by weight |
|---|---|---|
| MNZL Manzil Russell Halal USA Broad Market ETF | 0.17% | 88% |
| SPUS SP Funds S&P 500 Sharia Industry Exclusions ETF | 0.14% | 79% |
Widely held U.S. index funds. If you own one, you own BDX through it. None of them is a Shariah fund; the last column is our look-through of each.
| Fund | BDX in fund | Fund compliant by weight |
|---|---|---|
| RSP Invesco S&P 500 Equal Weight ETF | 0.22% | 44% |
| VYM VANGUARD HIGH DIVIDEND YIELD INDEX FUND | 0.19% | 46% |
| SCHB Schwab U.S. Broad Market ETF | 0.07% | 53% |
| SPY | 0.06% | 56% |
| VOO VANGUARD 500 INDEX FUND | 0.06% | 56% |
| SPYM State Street(R) SPDR(R) Portfolio S&P 500(R) ETF | 0.06% | 56% |
| IVV iShares Core S&P 500 ETF | 0.06% | 56% |
| VTI VANGUARD TOTAL STOCK MARKET INDEX FUND | 0.06% | 54% |
| ITOT iShares Core S&P Total U.S. Stock Market ETF | 0.06% | 54% |
| Fund | BDX in fund | Fund compliant by weight |
|---|---|---|
| IJMAX VY(R) JPMORGAN MID CAP VALUE PORTFOLIO Also IJMIX | 0.65% | 36% |
| MVGLX MFS Low Volatility Global Equity Fund | 0.65% | 49% |
| IIRMX Voya RussellTM Mid Cap Index Portfolio | 0.31% | 43% |
| VADRX Invesco Equally-Weighted S&P 500 Fund | 0.24% | 44% |
| GEW Cambria Global EW ETF | 0.18% | 41% |
| SCHV Schwab U.S. Large-Cap Value ETF | 0.16% | 48% |
| SPXN ProShares S&P 500 Ex-Financials ETF | 0.09% | 60% |
| JUST Goldman Sachs JUST U.S. Large Cap Equity ETF | 0.09% | 54% |
| SPGM State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF | 0.08% | 53% |
| GSLC Goldman Sachs ActiveBeta(R) U.S. Large Cap Equity ETF | 0.07% | 55% |
7 more funds
| Fund | BDX in fund | Fund compliant by weight |
|---|---|---|
| GRMAX Nationwide S&P 500 Index Fund | 0.07% | 53% |
| DXUV Dimensional US Vector Equity ETF | 0.07% | 43% |
| GDE WisdomTree Efficient Gold Plus Equity Strategy Fund | 0.07% | 47% |
| FSAKX Strategic Advisers U.S. Total Stock Fund | 0.07% | 40% |
| DFUS Dimensional U.S. Equity Market ETF | 0.07% | 53% |
| RAUS RACWI US ETF | 0.06% | 55% |
| IILGX THRIVENT GLOBAL STOCK FUND | 0.00% | 35% |
Sorted by BDX’s share of each fund, from the fund’s latest SEC N-PORT filing. “Compliant by weight” is the share of the fund’s holdings our look-through screens compliant. A fund is listed only where its filing is mostly equity and names BDX once, so a bond is not counted as the shares; 2 more funds name BDX in a way we cannot separate from its bonds, and are not listed. Shariah funds are those with a recorded certification, on our halal ETF list, or named Shariah, Islamic, Halal or Sukuk.
| Investor | Firm | Position | Weight | As of |
|---|---|---|---|---|
| First Eagle | First Eagle Investment Management | $2,485M | 3.9% | 2026-09-30 |
| Edgar Wachenheim | Greenhaven Associates | $1,057M | 13.3% | 2026-09-30 |
| Ken Griffin | Citadel Advisors | $524M | 0.1% | 2026-09-30 |
| Bill Nygren | Harris Associates (Oakmark) | $399M | 0.5% | 2026-09-30 |
| First Pacific Advisors | First Pacific Advisors | $383M | 4.6% | 2026-09-30 |
| Charles Brandes | Brandes Investment Partners | $295M | 2.0% | 2026-09-30 |
| Joel Greenblatt | Gotham Asset Management | $64M | 0.1% | 2026-09-30 |
| Steven Cohen | Point72 Asset Management | $59M | 0.1% | 2026-09-30 |
| Israel Englander | Millennium Management | $30M | 0.0% | 2026-09-30 |
| Jefferies | Jefferies Financial Group | $21M | 0.2% | 2026-09-30 |
| Paul Tudor Jones | Tudor Investment Corp | $11M | 0.0% | 2026-09-30 |
| Azzad Asset Management | Azzad Asset Management | $6M | 0.5% | 2026-09-30 |
| Jeff Auxier | Auxier Asset Management | $3M | 0.4% | 2026-06-30 |
| Mark Hillman | Hillman Capital Management | $3M | 1.9% | 2026-09-30 |
| David Shaw | D. E. Shaw & Co. | $2M | 0.0% | 2026-09-30 |
| Mario Gabelli | GAMCO Investors | $2M | 0.0% | 2026-09-30 |
| Ray Dalio | Bridgewater Associates | $2M | 0.0% | 2026-09-30 |
| Jeremy Grantham | GMO | $1M | 0.0% | 2026-09-30 |
| Mairs & Power | Mairs & Power | $1M | 0.0% | 2026-09-30 |
| Jensen Investment Management | Jensen Investment Management | $0M | 0.0% | 2026-09-30 |
| Sallie Krawcheck | Ellevest | $0M | 0.0% | 2026-09-30 |
| Lee Ainslie | Maverick Capital | $0M | 0.0% | 2026-09-30 |
From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 69.70 | NEUTRAL |
| Stochastic %K (14) | 80.87 | SELL |
| CCI (20) | 81.22 | NEUTRAL |
| Williams %R (14) | -19.13 | SELL |
| MACD (12,26,9) | 0.58 | BUY |
| ROC (10) | 8.71 | BUY |
| Momentum (10) | 17.25 | BUY |
| EMA (10) | 212.69 | BUY |
| SMA (10) | 214.26 | BUY |
| EMA (20) | 206.89 | BUY |
| SMA (20) | 205.79 | BUY |
| EMA (30) | 202.38 | BUY |
| SMA (30) | 199.92 | BUY |
| EMA (50) | 195.64 | BUY |
| SMA (50) | 192.29 | BUY |
| EMA (100) | 184.41 | BUY |
| SMA (100) | 180.88 | BUY |
| EMA (200) | 172.10 | BUY |
| SMA (200) | 167.74 | BUY |
About Becton Dickinson & Co.
Healthcare · Medical Instruments & Supplies
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Background via Yahoo Finance — informational, not part of the verdict.
Latest Signal — 2026-11-17
Stop 0.06 Now 215.42 Target 0.09
Weak — low conviction, small size or skip
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BULLISH | 64 |
| ⏰ 4H | BULLISH | 37 |
| 🕐 1H | RANGING | 98 |
| ⏱ 15-Min | RANGING | 130 |
| ⏲ 5-Min | RANGING | 234 |
Momentum & Volume
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
Peer Movement
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is this a fatwa?
No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.
Why can the standards disagree?
Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.
How often is this re-screened?
Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.
Do I need to purify dividends?
If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Insider Activity (90d)
Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.
CLUSTER SELL 0 buys · 6 sells
Recent: Polen Thomas E Jr sold 110163 sh @ $185.00 (2026-08-13); Feld Michael sold 19720 sh @ $188.49 (2026-08-26); Feld Michael sold 20934 sh @ $157.13 (2026-07-27)
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-11-10 · Asset managers net 914130 (-14454)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.